“…The concentration of DMOG used to treat bone defects varied among studies due to different culture conditions. DMOG was incorporated into various scaffolds to investigate its impact on bone defects regeneration including gelatin sponge (GS) [43], β-tricalcium phosphate (β-TCP) [45], calcined bone calcium (CBC) scaffolds [58], nanoscale zeolitic imidazolate frameworks-8 (ZIF-8) and sodium alginate hydrogel (SA) [59], mesoporous silica nanospheres (MSN) [60][61][62], PCL grafts [61], nanofibrous gelatin-silica hybrid scaffold (GP) [62], natural wood elastic scaffolds [63], mesoporous bioactive glass (MBG) [64,65], sodium alginate-gelatin-β-tricalcium phosphate [66], nanocomposite hydrogel [67], poly (lactic-co-glycolic acid) fiber (PLGA) [68], nanoporous silica nanoparticles (NPSNPs) [69], MBG-dopedpoly(3-hydroxybutyrate-co-3-hydroxyhexanate) (PHMG) [72],calcium phosphate microparticle-s (CMPs) [73], metal-organic frameworks (MOFs) [74], polylactic acid scaffold (PLLA) [76], beaver nano hydrogel, chitosan (CS) and hydroxy propyl chitin hydrogel (HPCH) [77], and particulate-engineered scaffold [78]. The treatment duration ranged from 7 days to 18 weeks.…”